A detailed history of Simplex Trading, LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 2,734 shares of EWTX stock, worth $71,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,734
Previous 3,025 9.62%
Holding current value
$71,330
Previous $55,000 10.91%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$15.08 - $21.23 $4,388 - $6,177
-291 Reduced 9.62%
2,734 $49,000
Q1 2024

Apr 25, 2024

BUY
$9.25 - $19.97 $27,981 - $60,409
3,025 New
3,025 $55,000
Q3 2023

Nov 01, 2023

SELL
$5.73 - $7.69 $12,365 - $16,595
-2,158 Reduced 85.33%
371 $2,000
Q2 2023

Aug 04, 2023

SELL
$5.71 - $10.29 $2,546 - $4,589
-446 Reduced 14.99%
2,529 $19,000
Q1 2023

Apr 27, 2023

BUY
$6.66 - $11.33 $19,813 - $33,706
2,975 New
2,975 $19,000

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.65B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.